A Cross-sectional, Retrospective Screening and Case-control Study Examining the Frequency of, and Risk Factors Associated With, Impulse Control Disorders in Parkinson's Disease Patients Treated With MIRAPEX® (Pramipexole) and Other Anti-parkinson Agents (DOMINION Study)

Trial Profile

A Cross-sectional, Retrospective Screening and Case-control Study Examining the Frequency of, and Risk Factors Associated With, Impulse Control Disorders in Parkinson's Disease Patients Treated With MIRAPEX® (Pramipexole) and Other Anti-parkinson Agents (DOMINION Study)

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Nov 2013

At a glance

  • Drugs Antiparkinsonians; Pramipexole
  • Indications Parkinson's disease
  • Focus Adverse reactions
  • Acronyms DOMINION
  • Most Recent Events

    • 24 Jun 2010 Actual end date (Sep 2006) added as reported by ClinicalTrials.gov.
    • 24 Jun 2010 Actual initiation date (Jan 2008) added as reported by ClinicalTrials.gov.
    • 16 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top